Qu P, Li Y, Hu X, Guo Y, Zhu Y, Li X, Zhao J
Taiyuan Central Hospital, Department of Endocrinology, Shanxi Medical University, Shanxi, China.
Shanxi Medical University Second Affiliated Hospital, Department of Osteology, Shanxi, China.
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):168-176. doi: 10.4183/aeb.2021.168.
To observe the effect of adiponectin on osteogenesis in type 2 diabetic rats.
The 4th-week-old male SD rats were divided into normal control group (n=18) and diabetic model group (n = 42). Type 2 diabetes was induced by high-fat and high-sugar diet and intraperitoneal injection of a low dose of streptozotocin (STZ). The successfully-induced diabetic rats were divided into diabetic group (DM=18) and adiponectin intervention group (APN=18). APN group was injected with APN 10 μg/kg*d. The rats were separately sacrificed at the 4, 8 and 12 week after the intervention. Bone microstructure and adipose tissue were observed via HE staining. Bone marrow was extracted from one side of the femur, and the supernatant was achieved by centrifugation. After BMD assessed by DXA, the other side of the femur was for further HE staining. Runx-2 expression in the bone marrow cells was detected by RT-PCR. BALP and AOPPs in bone marrow supernatant were assayed by ELISA. AGEs were detected by immunohistochemical staining.
With the feeding time over, blood glucose, AOPP, and AGEs were increased, and Runx-2 mRNA, BALP, BMD were decreased in diabetic rat group(P<0.05). Oxidative stress (OS) maker (AOPP) was decreased and osteogenesis makers (Runx2 mRNA, BALP) were increased after intervention with exogenous adiponectin (P<0.05). At the 8 and 12 week, the trabecular bone became thinner and broken, and the fat cell number increased in all 3 groups, especially in the DM group. The adiponectin intervention group showed that the trabecular bone structure was moderately restored.
OS is obvious in bone micro-environment in diabetic rats. OS may have an inhibitory effect on regulation of osteogenic differentiation factor Runx2, causing down regulation of osteoblast differentiation and bone formation. Adiponectin may improve OS response and protect the bone structure.
观察脂联素对2型糖尿病大鼠成骨作用的影响。
将4周龄雄性SD大鼠分为正常对照组(n = 18)和糖尿病模型组(n = 42)。采用高脂高糖饮食联合腹腔注射低剂量链脲佐菌素(STZ)诱导2型糖尿病。将成功诱导的糖尿病大鼠分为糖尿病组(DM = 18)和脂联素干预组(APN = 18)。APN组以10 μg/kg*d的剂量注射脂联素。干预后第4、8和12周分别处死大鼠。通过HE染色观察骨微观结构和脂肪组织。从一侧股骨提取骨髓,离心后获得上清液。通过双能X线吸收法(DXA)评估骨密度(BMD)后,另一侧股骨用于进一步的HE染色。通过逆转录聚合酶链反应(RT-PCR)检测骨髓细胞中Runx-2的表达。采用酶联免疫吸附测定法(ELISA)检测骨髓上清液中的骨碱性磷酸酶(BALP)和晚期氧化蛋白产物(AOPPs)。通过免疫组织化学染色检测晚期糖基化终末产物(AGEs)。
随着喂养时间延长,糖尿病大鼠组血糖、AOPPs和AGEs升高,Runx-2 mRNA、BALP和BMD降低(P < 0.05)。外源性脂联素干预后,氧化应激(OS)标志物(AOPP)降低,成骨标志物(Runx2 mRNA、BALP)升高(P < 0.05)。在第8周和第12周,所有3组的小梁骨均变细且断裂,脂肪细胞数量增加,尤其是DM组。脂联素干预组显示小梁骨结构得到适度恢复。
糖尿病大鼠骨微环境中OS明显。OS可能对成骨分化因子Runx2的调节具有抑制作用,导致成骨细胞分化和骨形成下调。脂联素可能改善OS反应并保护骨结构。